Axa’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-458,600
| Closed | -$596K | – | 1148 |
|
|
2023
Q2 | $596K | Buy |
+458,600
| New | +$596K | ﹤0.01% | 926 |
|
|
2023
Q1 | – | Sell |
-291,800
| Closed | -$916K | – | 1177 |
|
|
2022
Q4 | $916K | Hold |
291,800
| – | – | ﹤0.01% | 901 |
|
|
2022
Q3 | $1.43M | Buy |
+291,800
| New | +$1.43M | 0.01% | 810 |
|
|
2021
Q1 | – | Sell |
-48,100
| Closed | -$751K | – | 1320 |
|
|
2020
Q4 | $751K | Buy |
48,100
+35,000
| +267% | +$546K | ﹤0.01% | 1019 |
|
|
2020
Q3 | $124K | Buy |
13,100
+1,300
| +11% | +$12.3K | ﹤0.01% | 1180 |
|
|
2020
Q2 | $106K | Buy |
+11,800
| New | +$106K | ﹤0.01% | 1203 |
|